Levy S S - OmicsDI

Show results for

Unknown (4467)
Proteomics (86)
Transcriptomics (81)
Genomics (19)
Metabolomics (9)
Genomic (5)
Models (1)

Organisms

Homo sapiens (71)
Aerococcus urinae NBRC 15544 = CCUG 36881 (68)
Andropogon gerardi (68)
Bacteria (68)
Bartonella quintana JK 31 (68)
Canis lupus familiaris (68)
Cnidaria (68)
Ectopseudomonas oleovorans CECT 5344 (68)
Ensifer adhaerens (68)
Halictus scabiosae (68)
Human immunodeficiency virus 1 (68)
Mesocricetus auratus (68)
Miscanthus x giganteus (68)
Mus musculus (68)
Panicum virgatum (68)
Pseudomonas aeruginosa PA103 (68)
Pseudomonas aeruginosa SJTD-1 (68)
Rabies virus Nishigahara RCEH (68)
Rattus norvegicus (68)
Mus musculus (14)
Zea mays (4)
Saccharomyces cerevisiae (4)
Acropora millepora (1)
Eucalyptus grandis (1)
Saccharomyces paradoxus (1)
Yersinia pestis (1)
Solanum lycopersicum (1)
Triticum aestivum (1)
Rattus norvegicus (1)
Sus scrofa (1)

Repository

biostudies-arrayexpress (84)
pride (68)
EGA (17)
MassIVE (16)
MetaboLights (8)
dbGaP (5)
BioModels (1)
GNPS (1)
jPOST (1)

Tissue

Cell culture (17)
Epithelial cell (8)
T cell (8)
B cell (7)
Blood (7)
Blood plasma (5)
Brain (4)
Blood cell (3)
Blood serum (3)
Cell suspension culture (3)
Lung (3)
Melanocyte (3)
Permanent cell line cell (3)
Skin (3)
Spleen (3)
Cervicovaginal fluid (2)
Colon (2)
Kidney (2)
Liver (2)
Lymph node (2)
Melanoma cell (2)
Anatomical entity (1)
Breast (1)
Breast cancer cell line (1)
Cell in vitro (1)
LCL-721 cell (1)
LNCaP cell (1)
MiaPaCa-2 cell (1)
SW-620 cell (1)
T-lymphocyte (1)

Disease

Melanoma (6)
Colon cancer (3)
Disease free (3)
Pancreatic ductal adenocarcinoma (2)
HPV positive (1)
Acute myeloid leukemia (1)
Alzheimer's disease (1)
Burkitt lymphoma (1)
COVID-19 (1)
Castration-resistant prostate carcinoma (1)
Chronic lymphocytic leukemia (1)
Dementia (1)
Follicular lymphoma (1)
Head and neck squamous cell carcinoma (1)
Human immunodeficiency virus infectious disease (1)
Influenza (1)
Lung non-squamous non-small cell carcinoma (1)
Lymphoma (1)
Mantle cell lymphoma (1)
Neurodevelopmental delay (1)
Pancreatic cancer (1)
Pediatric osteosarcoma (1)
Skin melanoma (1)
Trypanosomiasis (1)

Technology Type

Mass Spectrometry (68)
Shotgun proteomics (37)
Affinity purification coupled with mass spectrometry proteomics (13)
Bottom-up proteomics (8)
Mass spectrometry (6)
Data-dependent acquisition (6)
Data-independent acquisition (4)
Illumina HiSeq 2500, ILLUMINA (2)
All-ion fragmentation (2)
DiaPASEF (2)
Top-down proteomics (2)
NMR spectroscopy (1)
Mass spectrometry assay (1)
Affinity proteomics (1)
Chemical cross-linking coupled with mass spectrometry proteomics (1)
Glycoproteomics (1)
HDMSE (1)
MSE (1)
SWATH MS (1)

Instrument Platform

Q Exactive (6)
LTQ (4)
LTQ Orbitrap Elite (3)
Orbitrap Fusion Lumos (2)
LTQ Orbitrap Velos (2)
LTQ XL (2)
Illumina HiSeq 3000 (1)
MALDI Synapt G2-S HDMS (1)
Orbitrap Eclipse (1)
Q Exactive HF (1)
Q Exactive Plus (1)
Thermo Fusion Lumos (1)
Liquid Chromatography MS – NEG (1)
Liquid Chromatography MS – POS (1)
Liquid Chromatography MS - - - Q Exactive (1)
Liquid Chromatography Tandem MS (LC-MS/MS) (1)
Bruker (1)
Gas Chromatography MS - positive (1)

Publication Date

2022 (19)
2013 (16)
2015 (13)
2025 (12)
2011 (11)
2023 (11)
2021 (11)
2010 (10)
2016 (9)
2024 (8)
2014 (7)
2009 (7)
2018 (7)
2026 (7)
2019 (7)
2017 (6)
2012 (6)
2007 (4)
2020 (4)
2006 (2)
2008 (1)
2002 (1)

CHEBI ID

CHEBI:26986 (5)
CHEBI:133148 (4)
CHEBI:28101 (4)
CHEBI:17716 (4)
CHEBI:17822 (4)
CHEBI:26271 (4)
CHEBI:22660 (4)
CHEBI:18186 (4)
CHEBI:28757 (4)
CHEBI:37684 (4)
CHEBI:16811 (4)
CHEBI:17234 (4)
CHEBI:24898 (4)
CHEBI:25017 (4)
CHEBI:17754 (4)
CHEBI:15963 (4)
CHEBI:28044 (4)
CHEBI:16566 (4)
CHEBI:27266 (4)
CHEBI:25094 (4)
CHEBI:18257 (4)
CHEBI:6650 (4)
CHEBI:18237 (4)
CHEBI:16958 (4)
CHEBI:16113 (4)
CHEBI:32816 (4)
CHEBI:78320 (4)
CHEBI:15428 (4)
CHEBI:33508 (4)
CHEBI:16449 (4)

Metabolite Name

Sphinganine (4)
Sertraline (3)
Pantoate (3)
L-urobilin (3)
Valylglycine (3)
Beta-citrylglutamate (3)
Isoleucylglycine (3)
N1,N12-diacetylspermine (3)
Tryptophan betaine (3)
Theophylline (3)
Theobromine (3)
Tartarate (3)
Pregnanediol-3-glucuronide (3)
Maltotriose (3)
Cysteinylglycine (3)
5alpha-pregnan-3beta,20alpha-diol disulfate (3)
4-acetaminophen sulfate (3)
3-methyladipate (3)
1,7-dimethylurate (3)
1,3,7-trimethylurate (3)
2-hydroxy-4-(methylthio)butanoic acid (3)
3-hydroxydecanoylcarnitine (3)
2,6-dihydroxybenzoic acid (3)
N6,N6-dimethyllysine (3)
2-hydroxysebacate (3)
3-amino-2-piperidone (3)
3-formylindole (3)
Lyxonate (3)
2'-O-methyluridine (3)
Ascorbic acid 2-sulfate (3)

IsPrivate

False (1)

Model Flag

Non Kinetic (1)

Modelling Approach

Constraint-based model (1)

Study type

Transcription profiling by array (52)
Comparative genomic hybridization by array (8)
RNA-seq of coding RNA (7)
RNA-seq of non coding RNA (5)
Genotyping by array (4)
Methylation profiling by array (3)
Transcription profiling by SAGE (1)
Unknown experiment type (1)
ChIP-seq (1)
Proteomic profiling by array (1)
Methylation profiling by high throughput sequencing (1)

Release Date

2022 (521)
2021 (508)
2025 (437)
2023 (425)
2024 (378)
2020 (322)
2019 (301)
2018 (228)
2016 (211)
2017 (210)
2015 (207)
2014 (158)
2013 (116)
2012 (106)
2011 (100)
2010 (90)
2009 (71)
2026 (45)
2008 (40)
2007 (22)
2006 (15)
2004 (9)
2001 (9)
2002 (5)
2005 (5)
2003 (5)
1998 (3)
2000 (2)
1999 (2)

Lab affiliation

Department of Human Genetics and Biochemistry Sackler School of Medicine Tel Aviv University Tel-Aviv, Israel 69978 (5)
Stowers Institute for Medical Research (4)
Department of Chemical & Systems Biology, Stanford University, USA (3)
Head of the Curie Institute Mass Spectrometry Platform (3)
Department of Chemical & Systems Biology Stanford University USA (2)
Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel (2)
1. Proteomics Facility, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands; 2. Biomolecular Mass Spectrometry and Proteomics, Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Padualaan 8, 3584 CH, Utrecht, the Netherlands (1)
1.Precision Vaccines Program, Division of Infectious Diseases, Boston Children’s Hospital, Boston, MA, USA. 2. Department of Pediatrics, Harvard Medical School, Boston, MA, USA. (1)
95 Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III - Paul Sabatier (UT3), Toulouse, 31077, France (1)
Biosciences and bioengineering Department, IIT Bombay (1)
Boston Children's Hospital and Harvard Medical School (1)
Cancer Proteomics Lab Department of Molecular Cell Biology Weizmann Institute of Science, Rehovot (1)
Computational Systems Biochemistry, Max Planck Institute of Biochemistry, Am Klopferspitz 18, 82152 Martinsried, Germany; Verily Life Sciences, 269 E Grand Ave, South San Francisco, CA 94080, USA (1)
Department of Biochemistry, University of Washington, School of Medicine, Seattle, WA 98195, USA (1)
Department of Biochemistry, University of Washington, Seattle, Washington 98195, USA Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, Washington 98109, USA (1)
Department of Chemistry & Chemical Biology, Northeastern University (1)
Department of Ecology, Evolution and Behavior Alexander Silberman Institute of Life Sciences Faculty of Science The Hebrew University of Jerusalem (1)
Department of Medicine, Weill Cornell Medicine, New York, NY, USA (1)
Department of Molecular Cell Biology The Weizmann Institute of Science Rehovot, Israel (1)
Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. (1)
Department of Pathology, Boston Children's Hospital / Harvard Medical School (1)
Department of Pathology, Microbiology, and Immunology Vanderbilt University School of Medicine Nashville, TN 37232 USA (1)
Departments of Pathology, Boston Children’s Hospital and Harvard Medical School, Boston, MA, USA (1)
Dept. of Biological Chemistry The Institute of Life Science The Hebrew University of Jerusalem Jerusalem 91904, Israel (1)
Dept. of Biological Chemistry,The Alexander Silberman Institute of Life Science, The Hebrew University of Jerusalem,Givat Ram Campus, Jerusalem, 91904, Israel (1)
Dept. of Molecular and Cellular Biology, University of Geneva (1)
Division of Oncogenomics, Oncode institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands; (1)
Faculty of Biochemistry, Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel (1)
Gladstone Institure for Immunology; The J David Gladstone Institutes; San Francisco, CA, USA (1)
Harvard Medical School (1)

Previous page
1 / 467
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 467
Next page

Sort by:

Relevance

Page size

XRCC1 interacts with the p58 subunit of DNA Pol alpha-primase and may coordinate DNA repair and replication during S phase.

Not available

S-EPMC2691816 | biostudies-literature

ADH1 deletion cells upon growth on alternative carbon sources; Steady-state grown cells upon environmental perturbations

Cells must adjust their gene expression in order to compete in a constantly changing environment. Two alternative strategies could in principle ensure optimal coordination of gene expression with physiological requirement. First, the internal physiological state itself could feedback to regulated ge...

ORGANISM(S): Saccharomyces cerevisiae

2007-02-28 | E-GEOD-6302 | biostudies-arrayexpress

Miniaturized Capsule System Toward Real-Time Electrochemical Detection of H₂ S in the Gastrointestinal Tract.

Not available

S-EPMC11468942 | biostudies-literature

Implications of Brexit on the effectiveness of the UK soft drinks industry levy upon CHD in England: a modelling study.

Not available

S-EPMC10260949 | biostudies-literature

Li1.6AlCl3.4S0.6: a low-cost and high-performance solid electrolyte for solid-state batteries.

Not available

S-EPMC11707523 | biostudies-literature

The impact of the UK soft drink industry levy on the soft drink marketplace, 2017-2020: An interrupted time series analysis with comparator series.